Medicine and Dentistry
Acute Pulmonary Embolism
23%
Ambrisentan
6%
Anemia
18%
Angioplasty
18%
Anticoagulant Therapy
22%
Antiphospholipid Antibody
9%
Antiphospholipid Syndrome
18%
Atrial Septal Defect
18%
Bleeding
18%
Brain Natriuretic Peptide
11%
Cardiac Catheterization
15%
Cardiovascular System
7%
Chronic Thromboembolic Pulmonary Hypertension
100%
COVID-19 Vaccination
18%
Dasatinib
18%
Dyspnea
7%
Echocardiography
6%
Hazard Ratio
8%
Heart Left Ventricle Ejection Fraction
6%
Hemodynamic
20%
Idiopathic Thrombocytopenic Purpura
18%
Kyphoscoliosis
18%
Lung Artery Pressure
10%
Lung Vascular Resistance
18%
Major Bleeding
15%
Myeloproliferative Disorder
23%
Oxygen Therapy
6%
Platelet
11%
Prevalence
10%
Primary Immunodeficiency
18%
Pulmonary Artery Occlusion Pressure
6%
Pulmonary Embolism
10%
Pulmonary Hypertension
70%
Splenectomy
23%
Systolic Blood Pressure
6%
Thrombocytopenia
18%
Vaccination Coverage
18%
Vaccine Hesitancy
18%
Venous Thromboembolism
37%
Pharmacology, Toxicology and Pharmaceutical Science
Ambrisentan
6%
Anemia
18%
Anticoagulant Agent
18%
Bleeding
18%
Brain Natriuretic Peptide
8%
Chronic Thromboembolic Pulmonary Hypertension
65%
Kyphoscoliosis
18%
Obstruction
7%
Prevalence
7%
Pulmonary Hypertension
45%
Survival Rate
7%
Venous Thromboembolism
37%